CRM Investigational Product Management 2 — Questions and Answers
Question 1: What is a Certificate of Analysis (CoA) used for in the context of investigational product management?
- To document subject consent for experimental treatment
- To confirm the identity, purity, potency, and quality of the investigational product (Correct answer)
- To record adverse events related to the product
- To authorize shipment of product across international borders
Correct answer: To confirm the identity, purity, potency, and quality of the investigational product
A CoA is provided by the manufacturer and confirms the identity, purity, potency, and quality of the investigational product, ensuring it meets required specifications.
Question 2: At the end of a clinical trial, investigational product that has not been dispensed must typically be:
- Kept at the site indefinitely
- Returned to the sponsor or destroyed per protocol and documented (Correct answer)
- Given to site staff for personal use
- Donated to a local pharmacy
Correct answer: Returned to the sponsor or destroyed per protocol and documented
Undispensed IP must be returned to the sponsor or destroyed according to protocol requirements, and all actions must be fully documented in accountability records.
Question 3: What is 'blinding' in the context of investigational product management?
- A process to conceal the allocation of treatment so subjects or investigators are unaware of treatment assignment (Correct answer)
- A method to protect IP from light exposure
- A regulatory requirement for labeling IP in foreign languages
- A system for encrypting electronic drug dispensing records
Correct answer: A process to conceal the allocation of treatment so subjects or investigators are unaware of treatment assignment
Blinding refers to concealing treatment assignment from subjects, investigators, or both to prevent bias in the assessment of study outcomes.
Question 4: Which of the following is required on the label of an investigational product shipped to a U.S. clinical trial site?
- The subject's full name and date of birth
- A statement such as 'Caution: New Drug — Limited by Federal Law to Investigational Use' (Correct answer)
- The sponsor's quarterly revenue figures
- A list of all enrolled trial subjects
Correct answer: A statement such as 'Caution: New Drug — Limited by Federal Law to Investigational Use'
Per 21 CFR Part 312, investigational drug labels must include a statement limiting use to investigational purposes, along with protocol number, lot number, expiration date, and storage conditions.
Question 5: A randomization schedule in a blinded clinical trial is considered a form of:
- Adverse event documentation
- Essential document to be filed in the Trial Master File (Correct answer)
- Optional administrative record
- Subject recruitment material
Correct answer: Essential document to be filed in the Trial Master File
The randomization schedule is an essential document that must be filed in the Trial Master File (TMF) because it links treatment allocation to subject identifiers and is critical for data integrity.
Question 6: What is the purpose of an unblinding procedure in a clinical trial?
- To permanently reveal all treatment assignments to investigators at interim analysis
- To reveal a specific subject's treatment assignment in emergency medical situations (Correct answer)
- To allow sponsors to change the randomization scheme mid-trial
- To disclose proprietary formulation information to site staff
Correct answer: To reveal a specific subject's treatment assignment in emergency medical situations
Emergency unblinding allows a treating physician to learn a specific subject's treatment assignment when the information is necessary for appropriate medical management in an emergency.
Question 7: Which practice best ensures proper investigational product chain of custody during shipment from sponsor to site?
- Verbal confirmation between the shipping carrier and site staff
- Completion of shipping manifests, temperature monitoring logs, and signed receipts (Correct answer)
- Email notification from the sponsor only
- A single photograph of the package upon arrival
Correct answer: Completion of shipping manifests, temperature monitoring logs, and signed receipts
Chain of custody requires documented records including shipping manifests, continuous temperature monitoring logs, and signed receipts to verify product integrity and accountability throughout transit.
CRM Investigational Product Management 2
What is a Certificate of Analysis (CoA) used for in the context of investigational product management?